Genopsys Engages New Interim CEO

SOQUEL, California , April 7, 2008 – Genopsys, Inc., a protein engineering company based in Soquel, CA has announced the engagement of Larimore Cummins, M.D. as its interim CEO. Dr. Cummins comes to Genopsys from an extensive history of management in med-tech companies from startups to multinationals. His clinical background is in gastroenterology and biochemistry. He also currently serves as Chairman of Adaptive Clinical Solutions, Inc. of Marina, CA, and has recently served as CEO of that company's IP management division, Adaptive IP Solutions, LLC. He has served as founding CEO for three successful med-tech startups.

“We are delighted to welcome Dr. Cummins into this critical management role and look forward to his leadership as Genopsys makes that critical transition from an R&D company to a commercial venture,” commented Genopsys founder Eric Lietz, Ph.D.

About Genopsys
Genopsys, Inc., is an early-phase bioengineering company with offices in Soquel, California. The company is dedicated to the development of protein pharmaceuticals using its proprietary method of directed molecular evolution. Additional information is available at www.genopsys.com.